Artiva Biotherapeutics

1 Follower


Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.

Tom Farrell
Founder & Chief Strategy Officer
Peter Flynn
Chief Operating Officer
Jason Litten
Chief Medical Officer
Esther van den Boom
Chief Accounting Officer
Jennifer Bush
EVP, Chief Legal & People Officer
Michael Faerm
Chief Financial Officer
Eugene Helsel
VP, Regulatory Affairs & Quality
John Lim
VP, Clinical Operations
Heather Raymon
VP, Early Development & Program Management

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.